Lauren Floyd (@docl_floyd) 's Twitter Profile
Lauren Floyd

@docl_floyd

Renal Reg in North West, UK / Research interests in Vasculitis and GN / ERA YNP Board member

ID: 1386970705229754368

calendar_today27-04-2021 09:09:30

264 Tweet

373 Followers

293 Following

The UK Kidney Association (@ukkidney) 's Twitter Profile Photo

The Advanced Nephrology Course is back! 🗓️ 7 - 11 January 2025 📚 Perfect if you're preparing for the ESENeph or need a clinical update. 👥 BIG discounts for UKKA members 🎥 Recordings available High demand so book now: 🎟️ bit.ly/3yPCGiZ

The Advanced Nephrology Course is back! 
🗓️ 7 - 11 January 2025

📚 Perfect if you're preparing for the ESENeph or need a clinical update. 
👥 BIG discounts for UKKA members
🎥 Recordings available

High demand so book now:
🎟️ bit.ly/3yPCGiZ
Kidneys for Life (@kidneysforlife) 's Twitter Profile Photo

There are still spots available for our KFL Sunday Lunch - 6th October, 12.30-4pm Enjoy a delicious lunch and hear from our Chair of Trustees, Afshin Tavakoli who will be talking about Kidneys for Life and our future plans. app.donorfy.com/form/ZU81NH9BY…

There are still spots available for our KFL Sunday Lunch - 6th October, 12.30-4pm
Enjoy a delicious lunch and hear from our Chair of Trustees, <a href="/afshin6666/">Afshin Tavakoli</a> who will be talking about Kidneys for Life and our future plans. 

app.donorfy.com/form/ZU81NH9BY…
ERA - European Renal Association (@erakidney) 's Twitter Profile Photo

👩‍⚕️Being a young doctor is tough - experience takes time. #Mentorship and peer support are key to growth. 🎙️Join us in the 21st episode of our #ERAPodcast series, "#APinchOfSalt"🧂with Orsolya Cseprekál. 🎧 Hit play now ⁣👉 bit.ly/3SdsxU0

JASN_News (@jasn_news) 's Twitter Profile Photo

Long-term outcomes of rituximab-treated adult patients with podocytopathies are largely unknown. This study found that rituximab facilitated achievement of initial and long-term response in a majority of adult patients with difficult-to-treat podocytopathies.

Long-term outcomes of rituximab-treated adult patients with podocytopathies are largely unknown.
This study found that rituximab facilitated achievement of initial and long-term response in a majority of adult patients with difficult-to-treat podocytopathies.
hlhwu (@hhlwu) 's Twitter Profile Photo

Delighted to see our paper on the role of urinary volatile organic compounds as a metabolomic biomarker in CKD being covered on Physician's Weekly this week ! #CKD #omics #biomarker Kolling Institute Northern Sydney Local Health District University of Sydney physiciansweekly.com/metabolomic-as…

YNP of ERA (@ynptweets) 's Twitter Profile Photo

🔥 Our snapshot summary on a survey study on what patients with CKD actually want to know! doi.org/10.1093/ckj/sf… Jet Milders is the YNP author. Prepared by Lauren Floyd. ERA - European Renal Association CKJ

🔥 Our snapshot summary on a survey study on what patients with CKD actually want to know!

doi.org/10.1093/ckj/sf…

Jet Milders is the YNP author.

Prepared by <a href="/DocL_Floyd/">Lauren Floyd</a>.

<a href="/ERAkidney/">ERA - European Renal Association</a> <a href="/CKJsocial/">CKJ</a>
CKJ (@ckjsocial) 's Twitter Profile Photo

🤩Exciting days ahead for Membranous Nephropathy! While classic therapies have made strides, 20-30% of cases remain resistant. New agents—from anti-CD20 to CAR T-cell therapy are set to transform MN care with a precision-based approach. doi.org/10.1093/ckj/sf… Lauren Floyd

CKJ (@ckjsocial) 's Twitter Profile Photo

Patients with treatment-resistant hypertension & CKD💊 finerenone showed a ⬇in systolic BP compared to spironolactone (+/- K+ binder) 📉 but had a significantly ⬇ risk of hyperkalemia ⚖️ & fewer treatment discontinuations due to ⬆ potassium levels doi.org/10.1093/ckj/sf…

Patients with treatment-resistant hypertension &amp; CKD💊 finerenone showed a ⬇in systolic BP compared to spironolactone (+/- K+ binder) 📉 but had a significantly ⬇ risk of hyperkalemia ⚖️ &amp; fewer treatment discontinuations due to ⬆ potassium levels 

doi.org/10.1093/ckj/sf…
CKJ (@ckjsocial) 's Twitter Profile Photo

🧵by @PWoywodt 👉What do you know about cosmic kidney disease and have you ever contemplated a flight to Mars 🌃? 👉Space has always fascinated me and as a boy I was very fond of rockets 🚀 so an advance article in the Journal on Cosmic kidney disease intrigued me 🌌

YNP of ERA (@ynptweets) 's Twitter Profile Photo

👀 Check our new snapshot summary on fluid removal targets during intermittent renal replacement therapy for AKI! doi.org/10.1093/ckj/sf… @WBeaubien is the YNP author. Prepared by Safak Mirioglu. ERA - European Renal Association CKJ

👀 Check our new snapshot summary on fluid removal targets during intermittent renal replacement therapy for AKI! 

doi.org/10.1093/ckj/sf…

@WBeaubien is the YNP author.

Prepared by <a href="/smirioglu/">Safak Mirioglu</a>.

<a href="/ERAkidney/">ERA - European Renal Association</a> <a href="/CKJsocial/">CKJ</a>
YNP of ERA (@ynptweets) 's Twitter Profile Photo

🎄 1/ New thread summarising the recently published NDT paper by YNP of ERA author Richard Shemilt 🏴󠁧󠁢󠁳󠁣󠁴󠁿 Link to paper 👉academic.oup.com/ndt/article/39… 🧵by Kaitlin Mayne - this one is a particular privilege to feature since it is the work of many UofG SCMH colleagues🤩

YNP of ERA (@ynptweets) 's Twitter Profile Photo

1/ New thread on recently published CKJ paper by Luis Harrison using target trial emulation to assess impact of arteriovenous fistula 🩸 formation on kidney function decline 📉 Link 👉 doi.org/10.1093/ckj/sf… 🧵by Richard Shemilt